Bookmark
Forward
QuickView for acitretin (compound)
PubChem
| Name: | Acitretin |
|---|---|
| PubChem Compound ID: | 41317 |
| Description: | An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate. |
| Molecular formula: | C21H26O3 |
| Molecular weight: | 326.429 g/mol |
DrugBank
Identification
| Name: | Acitretin |
|---|---|
| Name (isomeric): | DB00459 |
| Drug Type: | small molecule |
| Description: | An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate. |
| Brand: | Acetretin, Soriatane |
| Category: | Keratolytic Agents |
| CAS number: | 55079-83-9 |
Pharmacology
| Indication: | For the treatment of severe psoriasis in adults. |
|---|---|
| Pharmacology: |
Acitretin is a retinoid. Retinoids have a structure similar to vitamin A and are involved in the normal growth of skin cells. Acitretin works by inhibiting the excessive cell growth and keratinisation (process by which skin cells become thickened due to the deposition of a protein within them) seen in psoriasis. It therefore reduces the thickening ...
show more » |
| Mechanism of Action: | The mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells. |
| Absorption: | Oral absorption of acitretin is optimal when given with food, and is linear and proportional with increasing doses from 25 to 100 mg. Approximately 72% (range 47% to 109%) of the administered dose was absorbed after a single 50 mg dose of acitretin was given to 12 healthy subjects. |
| Protein binding: | Over 99.9% bound to plasma proteins, primarily albumin. |
| Biotransformation: | Following oral absorption, acitretin undergoes extensive metabolism and interconversion by simple isomerization to its 13-cis form (cis-acitretin). Both parent compound and isomer are further metabolized into chain-shortened breakdown products and conjugates, which are excreted. |
| Route of elimination: | Both parent compound and isomer are further metabolized into chain-shortened breakdown products and conjugates, which are excreted. The chain-shortened metabolites and conjugates of acitretin and cis-acitretin are ultimately excreted in the feces (34% to 54%) and urine (16% to 53%). |
| Half Life: | 49 hours (range 33 to 96 hours) |
| Toxicity: | Oral, rat: LD50 = >4000 mg/kg. Symptoms of overdose include headache and vertigo. |
| Affected organisms: | Humans and other mammals |
Interactions
| Drug interaction: |
|
|---|
Targets
Enzymes
Carriers
